ABSTRACT
Cardiac disease exerts a major influence on the morbidity and mortality of dialysis patients, as demonstrated by the frequent occurrence of heart failure and ischemic heart disease (1), very high mortality rates (2), and high proportion of cardiac deaths (2). These adverse events can usually be attributed to disorders of cardiac muscle structure and function and/or disorders of perfusions (3). Hemodynamic, metabolic, and other risk factors are prevalent in dialysis patients, which predispose to various cardiac disorders, some of which may be amenable to intervention (4-6).
